Location History:
- Hoym, DE (1999 - 2003)
- Berlin, DE (1995 - 2004)
- Quedlinburg, DE (2000 - 2013)
Company Filing History:
8 out of 10,754 
6 out of 161 
5 out of 13 
Years Active: 1995-2013
Title: Uwe Sonnewald: Pioneer in Transgenic Plant Innovation
Introduction: Uwe Sonnewald, located in Quedlinburg, Germany, is a renowned inventor with an impressive portfolio of 26 patents. His work primarily focuses on the development of expression cassettes for the transgenic expression of nucleic acids in plants, paving the way for advancements in agricultural biotechnologies.
Latest Patents: Among his latest patents, Uwe has developed innovative expression cassettes and vectors featuring constitutive promoters derived from plants. These inventions enable the transgenic expression of nucleic acid sequences, particularly selection markers, in various organisms. The described technologies not only contribute to the transformation of plants but also lead to the generation of cultures, parts, or propagation materials derived from these transformed plants. Uwe's work has significant implications for producing food, animal feed, seeds, pharmaceuticals, and fine chemicals.
Career Highlights: Uwe Sonnewald has made significant contributions to the field through his positions in reputable companies. He has worked for BASF Aktiengesellschaft and Hoechst Schering Agrevo GmbH, where he leveraged his expertise in plant biotechnology to drive innovation and research.
Collaborations: Throughout his career, Uwe has collaborated with distinguished professionals, including Lothar Willmitzer and Ralf-Michael Schmidt. These collaborations have helped foster an environment of innovation and research excellence in plant transgenics.
Conclusion: Uwe Sonnewald's contributions to the field of biotechnology, particularly in the development of transgenic plants, have set a foundation for future research and applications in agriculture. His innovative approach enhances the potential for sustainable food production and the development of new pharmaceutical agents, marking him as a key figure in biotechnical advancements.